Pictet Asset Management
PTCT icon

Pictet Asset Management’s PTC Therapeutics PTCT Stock Holding History

Pictet Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.6M Sell
1,147,844
-35,876
-3% -$2.59M 0.09% 241
2026
Q1 		$80.1M Buy
1,183,720
+204,763
+21% +$14.5M 0.08% 239
2025
Q4 		$74.8M Sell
978,957
-429,017
-30% -$31.2M 0.07% 259
2025
Q3 		$86.2M Buy
1,407,974
+366,543
+35% +$19.1M 0.08% 240
2025
Q2 		$51.1M Sell
1,041,431
-1,027
-0.1% -$48.8K 0.05% 311
2025
Q1 		$54M Buy
1,042,458
+306,070
+42% +$15.3M 0.06% 291
2024
Q4 		$33.2M Buy
736,388
+381,319
+107% +$16.3M 0.04% 379
2024
Q3 		$13.3M Sell
355,069
-14,921
-4% -$500K 0.01% 581
2024
Q2 		$11.3M Sell
369,990
-456,086
-55% -$14.8M 0.01% 604
2024
Q1 		$24.2M Sell
826,076
-40,484
-5% -$1.13M 0.03% 455
2023
Q4 		$23.9M Buy
866,560
+62,202
+8% +$1.42M 0.03% 441
2023
Q3 		$18M Buy
+804,358
New +$29.9M 0.02% 482

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Pictet Asset Management's PTCT Position: Q2 2026 in Review

Pictet Asset Management reduced its PTC Therapeutics (PTCT) stake by 3% in Q2 2026, selling an estimated $2.59M and leaving 1,147,844 shares worth $93.6M. The position accounts for 0.09% of the portfolio, ranked #241.

Pictet Asset Management first reported a position in PTCT in Q3 2023 and has held it in 12 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Pictet Asset Management held 1,147,844 shares of PTC Therapeutics worth $93.6M as of Q2 2026.
  • Pictet Asset Management sold 35,876 PTC Therapeutics shares in Q2 2026, an estimated $2.59M.
  • PTC Therapeutics made up 0.09% of Pictet Asset Management's portfolio in Q2 2026, its #241 holding.
  • Pictet Asset Management first reported a position in PTC Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.